| 摘要 |
<p>The invention features a method for treating meoplastic cell growth in a patient, wherein the meoplastic cell is of non-lymphoid and non-monocytic origin. The method includes administering to the patient a molecule which is capable of specifically binding to a cytokine receptor expressed on the meoplastic cell, which molecule is capable of decreasing the viability of the meoplastic cell. The cytokine receptor is a receptor normally expressed on cells of lymphoid or monocytic origin.</p> |
